Protection from CMV infection with optimal cutoff of 7 cells/μL within 65 days
| Recovery . | Rcurrent or persistent CMV infection or CMVD (n, %) . | |
|---|---|---|
| Absent . | Present . | |
| Rapid | 28 (82) | 6 (18) |
| Delayed | 19 (50) | 19 (50) |
| Recovery . | Rcurrent or persistent CMV infection or CMVD (n, %) . | |
|---|---|---|
| Absent . | Present . | |
| Rapid | 28 (82) | 6 (18) |
| Delayed | 19 (50) | 19 (50) |
Rapid recovery of CMV-specific CD8+ T cells (≥ 7 tetramer-positive cells/μL in any blood sample during the first 65 days after transplantation) was associated with protection from CMV-related complications (P = .004).